39 Although GLP-1RAs continue to be promising therapies for T2D, their long-term efficacy for weight loss after halting treatment should be further improved
Our study utilized as-treated analysis which ceased the follow-up until the switch between two drugs
Establishing healthy eating patterns, staying adequately hydrated, and monitoring how your body responds to the medication are more important initial goals than achieving specific weight loss targets
The principal advantages of microparticulate delivery systems include controlled and sustained drug release, enhanced bioavailability, improved physicochemical stability, and site-specific targeting, all of which contribute to optimized therapeutic outcomes and increased patient adherence [35]
Simply inject on the new day and continue weekly from there
50,51,80-82 As with SGLT2i, guidelines recommend GLP1- RA as a preferred medication for people with T2DM